文献速递外周动脉疾病

透析患者下肢开放手术血运重建的当代结局

Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis.
PubMed 文献 · J Vasc Surg · 2017-04-05

基于NSQIP 2011–2014年34,941例下肢开放手术血运重建患者,比较1623例透析与33,318例非透析患者的30天结局。透析患者死亡率(7.8% vs 2.1%)、心梗、重返手术室、非计划再入院及大截肢率均更高,30天通畅率无差异。

要点

  • 透析患者下肢开放血运重建后30天死亡率7.8%,显著高于非透析者2.1%。
  • 透析患者大截肢率1.7%,约为非透析者0.57%的三倍。
  • 主髂双股动脉旁路透析患者死亡率最高,达25%。

核心结论

  • 尽管透析患者内科管理进步,下肢开放血运重建后的结局改善尚未实现。
  • 特定临床和手术因素增加透析患者不良结局风险,据此选择合适患者可改善管理。

研究设计与样本

  • 共34,941例下肢开放手术血运重建患者,排除创伤、急诊、动脉瘤及腔内病例。
  • 比较1623例透析患者与33,318例非透析患者的30天结局。

主要发现

  • 透析患者更年轻(66.0 vs 66.7岁,P<.01),重症肢体缺血比例更高(49.7% vs 33.1%,P<.01),合并症更多。
  • 透析患者死亡率7.8% vs 2.1%(P<.01),心梗3.5% vs 1.4%(P<.01),重返手术室6.1% vs 2.8%(P<.01),非计划再入院5.2% vs 2.9%(P<.01)。
  • 30天通畅率两组无差异(0.4% vs 0.4%,P=.56),大截肢率透析组1.7% vs 0.57%(P<.01)。
  • 透析患者中,主髂双股动脉旁路死亡率最高(25% vs 3.6%,P<.01)。
  • 股-远端旁路后透析患者非计划再手术7.9% vs 3.9%(P<.01),非计划再入院6.2% vs 3.7%(P<.01),住院时间延长(67.5% vs 47.3%,P<.01)。

关键数值与推荐

  • 透析患者不良结局危险因素包括高龄、非裔美国人种族和充血性心力衰竭。
  • 主髂双股动脉旁路透析患者死亡率25%,股-远端旁路后非计划再手术率7.9%。

临床怎么用

  • 术前应依据年龄、种族、心衰及拟行术式评估透析患者下肢开放血运重建风险。
  • 对主髂双股动脉旁路等高危术式需谨慎选择透析患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Peripheral arterial disease is a common comorbidity found in up to 38% of patients with end-stage renal disease (ESRD). With an increase in the survival rate of patients with ESRD by >25%, there is a lack of contemporary data on the safety of open surgical revascularization of the lower extremity (OSRLE) in this population of patients. We sought to identify the perioperative morbidity and mortality and independent risk factors of mortality in dialysis patients undergoing OSRLE. METHODS: We reviewed data from 34,941 patients who underwent OSRLE from January 2011 to December 2014 at all hospitals in North America participating in the National Surgical Quality Improvement Program (NSQIP). Trauma, emergencies, aneurysms, and endovascular cases were excluded. We compared the 30-day outcomes of 1623 patients on dialysis with those of 33,318 patients not on dialysis. RESULTS: Patients on dialysis were younger (66.0 vs 66.7; P < .01), were more likely to be treated for critical limb ischemia (49.7% vs 33.1%; P < .01), and had more comorbidities compared with patients not on dialysis. Dialysis patients had higher mortality (7.8% vs 2.1%; P < .01) and postoperative complication rates after OSRLE, including myocardial infarction (3.5% vs 1.4%; P < .01), return to the operating room (6.1% vs 2.8%; P < .01), and unplanned readmission (5.2% vs 2.9%; P < .01). Although 30-day patency was not different (0.4% vs 0.4%; P = .56) between the two study groups, major amputation rate was threefold higher in dialysis patients (1.7% vs 0.57%; P < .01). In addition, we identified multiple risk factors that predispose dialysis patients to worse outcome after OSRLE, including older age, African American race, and congestive heart failure. In a subgroup analysis by procedure, dialysis patients who underwent aortobifemoral bypass carried the highest mortality risk (25% vs 3.6%; P < .01). Dialysis patients had higher rates of unplanned reoperation (7.9% vs 3.9%; P < .01) and unplanned readmission (6.2% vs 3.7%; P < .01) and increased length of stay (67.5% vs 47.3%; P < .01) after femoral-distal bypass. CONCLUSIONS: With improvements in the medical care of ESRD patients resulting in a large increase in survival rates, little is known about how dialysis patients fare after OSRLE in the contemporary period. Our study shows that despite advances in the medical management of dialysis patients, improvements in outcomes after revascularization have not yet been realized. We found that specific clinical and procedural factors increase the risk for inferior results. Careful selection of dialysis patients suitable for OSRLE according to these risk factors may improve the management of this still high-risk vascular population.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Rao A, Baldwin M, Cornwall J, et al. Contemporary outcomes of surgical revascularization of the lower extremity in patients on dialysis. J Vasc Surg. 2017. PMID: 28390771. doi:10.1016/j.jvs.2017.01.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。